Italy: Stevanato Group to roadshow US IPO of 40 million shares at US$21 to US$24 per share

Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, plans to commence the roadshow for its proposed IPO of 40 million ordinary shares with an expected price between US$21.00 and US$24.00 per share, raising US$960m at the top end. The company has applied…

You must be a HMI Subscriber to view this content.

Subscribe Now »